1910 Genetics

About 1910 Genetics

1910 Genetics focuses on improving drug discovery by combining artificial intelligence with biological research. Their technology helps identify and develop treatments for diseases that are hard to treat using traditional methods, specifically targeting "undruggable" parts of the human proteome. The company works with pharmaceutical firms, research institutions, and healthcare providers to create new small molecule drugs and protein therapeutics more efficiently. Unlike many competitors, 1910 Genetics offers a complete platform that covers the entire early drug discovery process, from target identification to treatment design. Their goal is to find effective therapies for challenging medical conditions, particularly through partnerships and grants, such as those from the National Institutes of Health.